Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
4(24%)
Results Posted
57%(4 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_3
3
18%
Ph not_applicable
1
6%
Ph early_phase_1
5
29%
Ph phase_1
6
35%
Ph phase_2
1
6%
Ph phase_4
1
6%

Phase Distribution

11

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
5(29.4%)
Phase 1Safety & dosage
6(35.3%)
Phase 2Efficacy & side effects
1(5.9%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
1(5.9%)
N/ANon-phased studies
1(5.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

4

trials recruiting

Total Trials

17

all time

Status Distribution
Active(6)
Completed(7)
Terminated(3)
Other(1)

Detailed Status

Completed7
Recruiting4
Terminated2
Not yet recruiting2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
4
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (29.4%)
Phase 16 (35.3%)
Phase 21 (5.9%)
Phase 33 (17.6%)
Phase 41 (5.9%)
N/A1 (5.9%)

Trials by Status

terminated212%
completed741%
unknown16%
withdrawn16%
not_yet_recruiting212%
recruiting424%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT03107520Early Phase 1

Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH

Recruiting
NCT06329570Phase 1

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Recruiting
NCT06400004Phase 3

Lumason® Infusion vs. Bolus Administrations

Recruiting
NCT07274787Not Applicable

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Not Yet Recruiting
NCT05957042Early Phase 1

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Withdrawn
NCT07145801Phase 2

Y-90 Treatment Response Using Transarterial Radioembolization

Recruiting
NCT04718441Phase 1

Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)

Completed
NCT06600880Phase 1

Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau

Not Yet Recruiting
NCT05613946Phase 1

Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema

Completed
NCT04569799Phase 4

Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE

Completed
NCT03653702Phase 1

Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)

Unknown
NCT04150874Early Phase 1

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Terminated
NCT03954015Early Phase 1

Comparison of Three Methods for Early Detection of Breast Cancer

Completed
NCT02552238Phase 3

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Completed
NCT02522481Phase 3

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

Completed
NCT03147690Phase 1

Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children

Terminated
NCT03296852Early Phase 1

Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17